Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C

Clinical trial NCT00778843 · COMPLETED

Trial details

NCT number: NCT00778843
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2008-10-01
Primary completion: 2009-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.